181513-08-6

Basic information

• Product Name: AKOS BC-0111
• Synonyms: AKOS BC-0111;3-(2-(DIMETHYLAMINO)ETHOXY)ANILINE;AKOS BBV-016194;[2-(3-Aminophenoxy)ethyl]dimethylamine dihydrochloride
• CAS NO: 181513-08-6
• Molecular Formula: C₁₀H₁₆N₂O
• Molecular Weight: 180.249
• Mol File: 181513-08-6.mol

Chemical Properties

• Boiling Point: 305.4±22.0 °C(Predicted)
• Appearance: /
• Density: 1.044±0.06 g/cm3(Predicted)
• PKA: 8.75±0.28(Predicted)
• CAS DataBase Reference: AKOS BC-0111(CAS DataBase Reference)
• NIST Chemistry Reference: AKOS BC-0111(181513-08-6)
• EPA Substance Registry System: AKOS BC-0111(181513-08-6)

Safety Data

• Hazardous Substances Data: 181513-08-6(Hazardous Substances Data)

Upstream product

• 108-01-0 2-(N,N-dimethylamino)ethanol 
• 4143-61-7 diethyl diazodicarboxylate 
• 591-27-5 m-Hydroxyaniline 
• 91761-27-2 N,N-dimethyl-2-(3-nitrophenoxy)ethan-1-amine 
• 6116-74-1 2-(dimethylamino)ethyl methanesulfonate monohydrochloride 
• 13831-59-9 2-(3-nitrophenoxy)bromoethane 

Downstream Products

• 181512-05-0 5-methoxy-6-trifluoromethyl-1-[3-(2-dimethylamino)-ethoxyphenyl-carbamoyl]indoline 
• 880882-14-4 N-{3-[2-(dimethylamino)ethoxy]phenyl}-2-(7-nitro-1H-benzimidazol-1-yl)acetamide 
• 941318-93-0 N-[3-(3-{2-[(3-{[2-(Dimethylamino)ethyl]oxy}phenyl)amino]-4-pyrimidinyl}pyrazolo[1,5-a]pyridin-2-yl)phenyl]-2,2,2-trifluoroacetamide 
• 1089278-92-1 N-(2,6-difluorophenyl)-3-(3-{2-[(3-{[2-(dimethylamino)ethyl]oxy}phenyl)amino]-4-pyrimidinyl}imidazo[1,2-a]pyridin-2-yl)benzamide 
• 1242928-97-7 N-(3-(2-(dimethylamino)ethoxy)phenyl)-1,4-dihydro-6-(3,5-dimethyl-1H-pyrazol-1-yl)-1,2,4,5-tetrazin-3-amine 
• 1242928-89-7 N³-(3-(2-(dimethylamino)ethoxy)phenyl)-N⁶-benzyl-1,2,4,5-tetrazine-3,6-diamine 
• 1571073-65-8 1-(4-((2-((3-(2-(dimethylamino)ethoxy)phenyl)amino)pyrimidin-4-yl)oxy)naphthalen-1-yl)-3-(1-(p-tolyl)-3-(trimethylsilyl)-1H-pyrazol-5-yl)urea 
• 1573024-84-6 1-(4-((2-((3-(2-(dimethylamino)ethoxy)phenyl)amino)pyrimidin-4-yl)oxy)naphthalen-1-yl)-3-(3-(2-methylbut-3-yn-2-yl)-1-(p-tolyl)-1H-pyrazol-5-yl)urea 

Relevant articles and documents

MACROCYCLIC COMPOUND SERVING AS WEE1 INHIBITOR AND APPLICATIONS THEREOF

Disclosed in the present invention are a macrocyclic compound serving as a Weel inhibitor, and applications thereof in the preparation of drugs for treating Weel-related diseases. The present invention specifically relates to a compound represented by for

COMPOUNDS FOR REGULATING FAK AND/OR SRC PATHWAYS

The present application provides novel optionally substituted fused pyridine and pyrimidine bicyclic compounds and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful in co-regulating FAK and/or Src activity by administering a therapeutically effective amount of one or more of the compounds to a subject. By doing so, these compounds are effective in treating conditions associated with the dysregulation of the FAK and/or Src pathway. Advantageously, these compounds perform as dual FAK and/or Src inhibitors. A variety of conditions can be treated using these compounds and include diseases which are characterized by inflammation or abnormal cellular proliferation. In one embodiment, the disease is cancer.

IMIDAZOPYRIDINES AS A NOVEL SCAFFOLD FOR MULTI-TARGETED KINASE INHIBITION

Compounds that inhibit protein kinases, compositions containing the compounds and methods of treating diseases using the compounds are disclosed. Formula (I).

Antimalarial 3-arylamino-6-benzylamino-1,2,4,5-tetrazines

We report on novel 3-arylamino-6-benzylamino-1,2,4,5-tetrazines with potent activity against Plasmodium falciparum.

Metasubstituted thiazolidinones, their manufacture and use as a drug

This invention involves thiazolidinone of general formula (I) and its creation and use as inhibitors of polo like kinase (PLK) for the treatment of various diseases.

ANTIFUNGAL AGENTS

Compounds of formula (I), and pharmaceutically acceptable salts thereof, may be used in therapy, for example as antifungal agents: (I) wherein: Rl, R2, R3, R4, R5, R6, R7, X and X1 are as defined herein. Certain compounds of formula (I) are also provided. Compounds of formula (T), and agriculturally acceptable salts thereof, may also be used as agricultural fungicides.

CATECHOLAMINE SURROGATES USEFUL AS BETA 3 AGONISTS

Compounds of the formula STR1 and pharmaceutically acceptable salts thereof. These compounds are beta three adrenergic receptor agonists and are useful, therefore for example, in the treatment of diabetes, obesity and gastrointestinal diseases.